Intravitreal bevacizumab in a patient with neovascular glaucoma

被引：105

作者：

Kahook, MY ^{[1
]}

Schuman, JS ^{[1
]}

Noecker, RJ ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, UPMC, Eye Ctr,Eye & Ear Inst, Pittsburgh, PA USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING | 2006年 / 37卷 / 02期

关键词：

D O I：

10.3928/1542-8877-20060301-11

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The utility of intravitreal bevacizumab injection In a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophoto-coagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.

引用

页码：144 / 146

页数：3

共 7 条

[1]

Campochiaro P A, 1999, Mol Vis, V5, P34

[2] Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema [J].

Funatsu, H ;

Yamashita, H ;

Sakata, K ;

Noma, H ;

Mimura, T ;

Suzuki, M ;

Eguchi, S ;

Hori, S .

OPHTHALMOLOGY, 2005, 112 (05) :806-816

[3] Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J].

Kabbinavar, F ;

Hurwitz, HI ;

Fehrenbacher, L ;

Meropol, NJ ;

Novotny, WF ;

Lieberman, G ;

Griffing, S ;

Bergsland, E .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :60-65

[4] Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration - Twelve-week results of an uncontrolled open-label clinical study [J].

Michels, S ;

Rosenfeld, PJ ;

Puliafito, CA ;

Marcus, EN ;

Venkatraman, AS .

OPHTHALMOLOGY, 2005, 112 (06) :1035-1047

[5] Intravitreal bevacizumab for choroidal neovascularization and cystoid macular edema: A cost-effective treatment? [J].

Reichel, E .

OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :270-271

[6] Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion [J].

Rosenfeld, PJ ;

Fung, AE ;

Puliafito, CA .

OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :336-339

[7] Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration [J].

Rosenfeld, PJ ;

Moshfeghi, AA ;

Puliafito, CA .

OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :331-335

← 1 →